PPB - Services

Complaints, Feedback and Enquiry

๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐š๐ง๐ ๐๐จ๐ข๐ฌ๐จ๐ง๐ฌ ๐๐จ๐š๐ซ๐ ๐’๐ก๐š๐ซ๐ž๐ฌ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ๐ฌ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐–๐š๐ฅ๐ญ๐ž๐ซ ๐‘๐ž๐ž๐ ๐€๐ซ๐ฆ๐ฒ ๐ˆ๐ง๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ž ๐จ๐Ÿ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ˆ๐‘๐ ๐“๐ž๐š๐ฆ – 25th March 2024

ย  ย ย 
Nairobi, Kenya – On Monday, March 25th, 2024, a delegation from the Walter Reed Army Institute of Research (WRAIR) Institutional Review Board (IRB) visited the Pharmacy and Poisons Board (PPB) for a familiarization with the processes of PPB’s Expert Committee on Clinical Trials (ECCT). They were warmly received by PPB’s Chief Executive Officer, Dr. F. M. Siyoi, and the Chairman of the ECCT, Prof. Gilbert Kokwaro.

During the visit, Dr. Siyoi highlighted the significant advancements made by PPB in the field of clinical trials, including the development of a draft framework for parallel submission of applications. This step is aimed at improving the review timelines for clinical trials in the country.

The visiting team expressed appreciation for the strides taken by PPB in overseeing clinical trials, particularly in the automation of its processes, which facilitates a seamless approach to submissions.


Public Relations

Leave a comment

Your email address will not be published. Required fields are marked *